The purpose of this paper was to present the current knowledge on the prevention of group B streptococcus (GBS) neonatal infections and the status of prevention policies in European countries and to present the DEVANI pan- European program, launched in 2008. The aim of this program was to assess the GBS neonatal infection burden in Europe, to design a new vaccine to immunize neonates against GBS infections, to improve the laboratory performance for the diagnosis of GBS colonization and infection, and to improve the methods for the typing of GBS strains. The current guidelines for GBS prevention in different countries were ascertained and a picture of the burden before and after the instauration of prevention policies has been drawn. After the issue of the Centers for Disease Control and Prevention (CDC) guidelines, many European countries have adopted universal screening for the GBS colonization of pregnant women and intrapartum prophylaxis to colonized mothers. Nevertheless, some European countries continue advocating the risk factor approach to GBS prevention. Most European countries have implemented policies to prevent GBS neonatal infections and the burden of the disease has decreased during the last several years. Nevertheless, further steps are necessary in order to develop new strategies of prevention, to improve microbiological techniques to detect GBS colonization and infection, and to coordinate the prevention policies in the EU. © Springer-Verlag 2012.

Prevention of group B streptococcal neonatal disease revisited. the DEVANI European project / Rodriguez-Granger, J.; Alvargonzalez, J. C.; Berardi, A.; Berner, R.; Kunze, M.; Hufnagel, M.; Melin, P.; Decheva, A.; Orefici, G.; Poyart, C.; Telford, J.; Efstratiou, A.; Killian, M.; Krizova, P.; Baldassarri, L.; Spellerberg, B.; Puertas, A.; Rosa-Fraile, M.. - In: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. - ISSN 0934-9723. - 31:9(2012), pp. 2097-2104. [10.1007/s10096-012-1559-0]

Prevention of group B streptococcal neonatal disease revisited. the DEVANI European project

Berardi, A.;
2012

Abstract

The purpose of this paper was to present the current knowledge on the prevention of group B streptococcus (GBS) neonatal infections and the status of prevention policies in European countries and to present the DEVANI pan- European program, launched in 2008. The aim of this program was to assess the GBS neonatal infection burden in Europe, to design a new vaccine to immunize neonates against GBS infections, to improve the laboratory performance for the diagnosis of GBS colonization and infection, and to improve the methods for the typing of GBS strains. The current guidelines for GBS prevention in different countries were ascertained and a picture of the burden before and after the instauration of prevention policies has been drawn. After the issue of the Centers for Disease Control and Prevention (CDC) guidelines, many European countries have adopted universal screening for the GBS colonization of pregnant women and intrapartum prophylaxis to colonized mothers. Nevertheless, some European countries continue advocating the risk factor approach to GBS prevention. Most European countries have implemented policies to prevent GBS neonatal infections and the burden of the disease has decreased during the last several years. Nevertheless, further steps are necessary in order to develop new strategies of prevention, to improve microbiological techniques to detect GBS colonization and infection, and to coordinate the prevention policies in the EU. © Springer-Verlag 2012.
31
9
2097
2104
Prevention of group B streptococcal neonatal disease revisited. the DEVANI European project / Rodriguez-Granger, J.; Alvargonzalez, J. C.; Berardi, A.; Berner, R.; Kunze, M.; Hufnagel, M.; Melin, P.; Decheva, A.; Orefici, G.; Poyart, C.; Telford, J.; Efstratiou, A.; Killian, M.; Krizova, P.; Baldassarri, L.; Spellerberg, B.; Puertas, A.; Rosa-Fraile, M.. - In: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. - ISSN 0934-9723. - 31:9(2012), pp. 2097-2104. [10.1007/s10096-012-1559-0]
Rodriguez-Granger, J.; Alvargonzalez, J. C.; Berardi, A.; Berner, R.; Kunze, M.; Hufnagel, M.; Melin, P.; Decheva, A.; Orefici, G.; Poyart, C.; Telford, J.; Efstratiou, A.; Killian, M.; Krizova, P.; Baldassarri, L.; Spellerberg, B.; Puertas, A.; Rosa-Fraile, M.
File in questo prodotto:
File Dimensione Formato  
DEVANI_Project (Rodriguez-Granger, Eur J Clin MicroBiol Infect Dis 2012).pdf

non disponibili

Descrizione: Articolo principale
Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 190.2 kB
Formato Adobe PDF
190.2 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1168706
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 54
social impact